
Care Bare Rx Review
Best for: LGBTQ+-inclusive compounded GLP-1 telehealth
Care Bare Rx is an LGBTQ+-inclusive telehealth brand offering compounded semaglutide and tirzepatide starting at $199/month across all 50 states plus Puerto Rico, with brand-name Ozempic also available. Operates on the shared Lion MD clinician + 4-pharmacy network with Breeze Meds and Synergy Rx.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Care Bare Rx is a solid telehealth option with balanced features and pricing.
Care Bare Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Pricing model
- Scales with dose — higher doses cost more
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Care Bare Rx
Each dimension is scored algorithmically from Care Bare Rx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $199/mo, Care Bare Rx runs about 17% above the $170 median for GLP-1 providers. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
8.3/10Care Bare Rx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
7.3/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
7.9/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy (last checked 2026-06-03).
Accessibility10%
8.2/10Care Bare Rx treats patients in all 50 states.
Support10%
5.8/10Care Bare Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this Care Bare Rx review
Last checked 2026-06-03- Confirmed current pricing across 3 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Care Bare Rx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Care Bare Rx offers
Beyond GLP-1s, Care Bare Rx also offers these peptides — tap any for our evidence-based guide.
Pricing
Ready to get started?
Plans and promotions change often — check Care Bare Rx's current pricing and active discounts before you decide.
What we like
- Explicit LGBTQ+-inclusive, 'self-care with pride' brand positioning — rare in GLP-1 telehealth
- Covers all 50 states plus Puerto Rico
- Offers both compounded options ($199/mo) and brand-name Ozempic ($705/mo)
- Named physician team: Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD
- Four named 503A pharmacy partners: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx
- No FDA warnings or litigation on record
Watch-outs
- Runs on the same clinician network and pharmacies as Breeze Meds and Synergy Rx — the three are white-labeled storefronts on one operation
- Compounded medications are not FDA-approved
- No actual gender-affirming care or HRT pathway despite the inclusive framing
- Limited accreditation transparency — LegitScript claimed but no PCAB or ACHC seal
- Pharmacy partners are named, but per-batch testing and accreditation details aren't disclosed
Care Bare Rx: a GLP-1 brand built around 'self-care with pride'
Care Bare Rx is one of the only GLP-1 telehealth services that leads with an explicitly LGBTQ+-inclusive identity. Its 'self-care with pride' framing is genuinely unusual in a category dominated by clinical, gender-neutral marketing, and for a lot of people that welcome matters. If you've felt like an afterthought at other weight-loss clinics, the tone here is a real differentiator. Just know going in that the inclusive branding is about how you're greeted and spoken to — not a separate medical pathway. Underneath the friendly wordmark, this is a compounded semaglutide and tirzepatide operation that happens to run on the same machinery as a couple of other brands.
How the pricing actually works
Compounded medication starts at $199 a month, and that figure is bundled — it covers your telehealth visit, a personalized treatment plan, the monthly prescription, home shipping, and email and phone support. There's no separate consult fee layered on top, which keeps the math honest. For reference, the category median runs around $170 a month, so Care Bare Rx sits a touch above the middle of the pack rather than competing as a bargain leader.
Because dosing scales over time, the starting rate is a floor, not a guarantee. As your prescriber steps you up to higher doses, expect the monthly cost to climb. The site is upfront that price 'varies by dose and medication,' so treat $199 as the entry point and confirm where your specific dose lands before you commit.
Brand-name Ozempic, at brand-name prices
Unlike many compounding-only storefronts, Care Bare Rx will also dispense brand-name Ozempic if that's what you want. The catch is the cash price: it runs into the high seven hundreds a month, more than triple the compounded starting rate. That's roughly in line with what brand GLP-1s cost without insurance anywhere, so it isn't a markup unique to this provider — but it does mean the brand option is really only practical if you specifically need the FDA-approved product and are paying out of pocket regardless.
The medications and who actually fills them
The compounded drugs come from a named clinician group, Lion MD, led by Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD. Prescriptions are routed to one of four 503A compounding pharmacies the brand names openly: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx. Naming both the physicians and the pharmacies is more transparency than a lot of competitors offer, and it's a point in Care Bare Rx's favor.
That said, naming a pharmacy isn't the same as proving its quality. The brand doesn't publish per-batch potency or sterility testing, and accreditation detail is thin — there's a LegitScript claim but no visible PCAB or ACHC seal to back it up. Compounded GLP-1s are also not FDA-approved by definition, so you're trusting the pharmacy chain rather than a federal review.
The thing you should know: it's a white-label storefront
Here's the most important fact our verification turned up. Care Bare Rx's clinician network (Lion MD) and its exact four pharmacies are identical to those used by two other brands, Breeze Meds and Synergy Rx. In plain terms, these are three different-looking websites sitting on top of one underlying operation. There's nothing inherently wrong with that — the medication and care you get are the same as the siblings — but it changes how you should read the marketing. The LGBTQ+-inclusive identity is a brand layer, not a different medical product. If two clinics quote you the same starting price and one simply feels more welcoming, that's a perfectly valid reason to pick it; just don't assume you're getting a distinct or specialized service.
Where the 'inclusive' promise stops
This is the honest caveat. Despite branding centered on the LGBTQ+ community, Care Bare Rx offers no gender-affirming care and no HRT pathway. It's a weight-management service with welcoming copy, not a queer-focused clinic in any clinical sense. If you were hoping to consolidate GLP-1 treatment with hormone care or other identity-specific services under one roof, you won't find that here, and it's worth being clear-eyed about that before you sign up.
Who should choose it — and who should skip it
- Choose it if: the inclusive tone genuinely makes you more comfortable starting treatment, you want compounded semaglutide or tirzepatide nationwide, and you value having the prescribing physicians and pharmacies named upfront.
- Choose it if: you live somewhere remote — coverage spans all 50 states plus Puerto Rico, which is broader than many rivals.
- Skip it if: you're shopping purely on price; the starting rate is reasonable but sits above the category median, and several competitors on the same compounded drugs cost less.
- Skip it if: you want documented per-batch testing, PCAB/ACHC accreditation, or an FDA-approved product without paying brand cash prices.
- Skip it if: you specifically want gender-affirming care — the branding implies more than the service delivers.
Trust and medical oversight
On the reassuring side: there are no FDA warning letters and no litigation on record as of our last check, the corporate entity is a real Delaware company (CareBareRX, headquartered in Alpharetta, Georgia), and named physicians sign off on prescriptions. On the cautious side: accreditation transparency is limited, the compounded products aren't FDA-approved, and the shared-operation reality means you're not getting bespoke oversight. We rate verification confidence as moderate — solid enough to be legitimate, light enough that you should read the fine print. For how we weigh these factors, see our scoring methodology.
Bottom line
Care Bare Rx does one thing few rivals do — it makes LGBTQ+ patients feel explicitly welcome — and it backs that up with nationwide coverage, named providers, and transparent bundled pricing from $199 a month. But the welcome is the differentiator; the medicine is the same compounded GLP-1 you'd get from its sibling brands Breeze Meds and Synergy Rx. If the tone helps you actually start and stick with treatment, that's worth something real. If you're optimizing for the lowest price, the strongest accreditation paperwork, or genuine gender-affirming care, look elsewhere.
Worth pricing against RNK Health ($197/month) and Breeze Meds ($199/month) before you commit — both sit close to Care Bare Rx on cost and formulation.
Ready to start with Care Bare Rx?
Starting at $199/month. See current pricing and start your free consultation.
Care Bare Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Alternatives to Care Bare Rx
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Care Bare Rx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Care Bare Rx?
Starting at $199/month. See current pricing and start your free consultation.